Association of Genetic Polymorphisms with Complications of Implanted LVAD Devices in Patients with Congestive Heart Failure: A Kazakhstani Study

Zhalbinova M.R. Rakhimova S.E. Kozhamkulov U.A. Akilzhanova G.A. Kaussova G.K. Akilzhanov K.R. Pya Y.V. Lee J.H. Bekbossynova M.S. Akilzhanova A.R.
May 2022 MDPI

Journal of Personalized Medicine
2022 #12 Issue 5

The left ventricular assist device (LVAD) is one of the alternative treatments for heart failure (HF) patients. However, LVAD support is followed by thrombosis, and bleeding complications which are caused by high non-physiologic shear stress and antithrombotic/anticoagulant therapy. A high risk of complications occurs in the presence of the genotype polymorphisms which are involved in the coagulation system, hemostasis function and in the metabolism of the therapy. The aim of the study was to investigate the influence of single-nucleotide polymorphisms (SNP) in HF patients with LVAD complications. We analyzed 21 SNPs in HF patients (n = 98) with/without complications, and healthy controls (n = 95). SNPs rs9934438; rs9923231 in VKORC1, rs5918 in ITGB3 and rs2070959 in UGT1A6 demonstrated significant association with HF patients’ complications (OR (95% CI): 3.96 (1.42–11.02), p = 0.0057), (OR (95% CI): 3.55 (1.28–9.86), p = 0.011), (OR (95% CI): 5.37 (1.79–16.16), p = 0.0056) and OR (95% CI): 4.40 (1.06–18.20), p = 0.044]. Genotype polymorphisms could help to predict complications at pre-and post-LVAD implantation period, which will reduce mortality rate. Our research showed that patients can receive treatment with warfarin and aspirin with a personalized dosage and LVAD complications can be predicted by reference to their genotype polymorphisms in VKORC1, ITGB3 and UGT1A6 genes.

bleeding , genotype , heart failure , left ventricular assist device (LVAD) , personalized medicine , polymorphism , thrombosis

Text of the article Перейти на текст статьи

National Laboratory Astana, Nazarbayev University, Nur-Sultan, 010000, Kazakhstan
Department of General Biology and Genomics, L. N. Gumilyov Eurasian National University, Nur-Sultan, 010000, Kazakhstan
Semey Medical University, Pavlodar Branch, Pavlodar, 140000, Kazakhstan
Kazakhstan Medical University “KSPH”, Almaty, 050000, Kazakhstan
National Research Cardiac Surgery Center, Nur-Sultan, 010000, Kazakhstan
Sergievsky Center, Taub Institute, Columbia University Irving Medical Centerx, 630 W, New York, 10032, NY, United States

National Laboratory Astana
Department of General Biology and Genomics
Semey Medical University
Kazakhstan Medical University “KSPH”
National Research Cardiac Surgery Center
Sergievsky Center

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026